BlackRock Institutional Trust’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCRX
BFA
HM
GGHC
DCM
PHS
BlackRock Institutional Trust's PCRX Position: Q4 2016 in Review
BlackRock Institutional Trust increased its Pacira BioSciences (PCRX) stake by 1% in Q4 2016, buying an estimated $323K and bringing the position to 953,623 shares worth $30.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1649.
BlackRock Institutional Trust first reported a position in PCRX in Q2 2013 and has held it in 15 quarters since. The position peaked at $94.6M in Q1 2015. 182 funds tracked by Wall St. Rank hold PCRX as of Q4 2016.
- BlackRock Institutional Trust held 953,623 shares of Pacira BioSciences worth $30.8M as of Q4 2016.
- BlackRock Institutional Trust bought 9,689 Pacira BioSciences shares in Q4 2016, an estimated $323K.
- Pacira BioSciences made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1649 holding.
- BlackRock Institutional Trust first reported a position in Pacira BioSciences in Q2 2013 and has held it in 15 quarters since.
- BlackRock Institutional Trust's Pacira BioSciences position peaked at $94.6M in Q1 2015.
- 182 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2016.
Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.